secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2021-08-13T23:59:59+00:00
Accession:  0001493152-21-019797
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Abeona Therapeutics appoints Edward Carr as CFO, effective August 10, 2021
--------------------------------------------------------------------------

- Edward Carr, previously CAO, becomes CFO; continues as principal financial officer.
- Base salary of $400,000; annual bonus target of 40% of base salary.
- Receives 238,000 restricted stock units and options for 476,000 shares (10-year term).
- RSUs and options vest 25% on first anniversary, remainder over 36 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315221019797/0001493152-21-019797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315221019797/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-019797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer